locally advanced nasopharyngeal carcinoma
Conditions
Interventions
Group B:Increase 2 cycles of chemotherapy
Group A:2 cycles of chemotherapy
Sponsors
The Affiliated Hospital of Southwest Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. The pathological diagnosis of NPC; 2. Subjects voluntarily participated in the study, written informed consent, compliance, and with the follow-up; 3. Aged 18-70 years old; 4. AJCC(8th) stages are T3-4N2-3M0 or others what the cervical lymph node undergoing a needle biopsy without distant 5. ECOG is 0 to 2; 6. The normal function of major organs that blood routine and biochemical tests in line with chemoradiotherapy standards; 7. To be the first treatment.
Exclusion criteria
Exclusion criteria: 1. Pregnant and lactating women; 2. Chemoradiotherapy contraindications; 3. Can not be clearly described in the response to treatment; 4. Had received radiotherapy or Inconsistent induction chemotherapy; 5. suffers from mental illness, congestive heart failure, angina, hypertension are not yet control, myocardial infarction less than 6 months, active infectious disease,serious medical complications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The long-term efficacy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Term efficacy; | — |
Countries
China
Contacts
Public ContactJingbo Wu
Oncology Department of Affiliated Hospital of Southwest Medical University
Outcome results
None listed